Search

everythinglearnresearchcommunity

for

Search:↓

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Iron deficiency might contribute to hair loss in women.

Retinol may affect immune responses in people with frequent skin boils.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

lncRNAs are important for understanding and treating skin diseases.

People with alopecia have a higher risk of thyroid cancer.

Targeting NETs may help reduce fibrosis in Crohn's disease.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Future acne treatments should aggressively target inflammation to prevent scarring.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Traditional Chinese medicine may help treat ischemic stroke by targeting specific genes and pathways.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Spaceflight can harm skin health by altering gene expression, affecting DNA, mitochondria, and skin barriers.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

COVID-19 may trigger alopecia areata, but more research is needed.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

A Western diet may increase acne risk, while a Mediterranean diet and certain supplements can help reduce it.

Calcipotriene ointment improved a child's skin condition known as En coup de sabre.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.